Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

Annovis Bio Inc. Stock

Price
Target price
€2.53

€2.53

4.090%
0.1
4.090%
-
 
22:26 / Tradegate WKN: A2PNH2 / Name: Annovis Bio Inc. / Stock / ? /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Your prediction
Pros and Cons of Annovis Bio Inc. in the next few years
Wizard

Annovis Bio Inc. Stock

Annovis Bio Inc. dominated the market today, gaining €0.10 (4.090%).
For the coming years our community has positive and negative things to say abot the Annovis Bio Inc. stock. Criterium "Company culture" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
What does Annovis Bio Inc. do?

Pros and Cons of Annovis Bio Inc. in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

Analyzing the financials of Annovis Bio Inc. (US symbol: ANVS) reveals a company situated in a complex financial landscape. The overall impression suggests that the firm is in the early stages of its financial journey, marked by significant challenges as evidenced by its key financial ratios. The absence of revenue and profitability at this stage raises concerns, yet the potential for future growth cannot be disregarded. Let's delve deeper into the specifics of Annovis Bio Inc.'s financials, considering both the strengths and weaknesses that stand out.

Market Capitalization: With a market capitalization of approximately $101.92 million, Annovis Bio Inc. has a decent foothold within the biotech landscape. This relatively small market cap could attract investors looking for growth opportunities in emerging companies, especially in the high-stakes world of biotechnology.

Valuation Metrics: Despite the negative earnings, the company exhibits a Price to Book ratio of 19.49, which can indicate that investors are paying a premium for the company’s book value. This suggests that the market believes in a long-term growth potential, meaning Annovis Bio could have favorable developmental prospects.

Show more
Register To Post